Botswana Blood Products Import Market -- HS Code 3002 Trade Data & Price Trend (Mar 2025)

Botswana Blood Products Import (HS 3002) Key Takeaways

Botswana's Blood Products Import under HS Code 3002 surged to $3.86 million in March 2025, driven by high-value human vaccines and specialized biologicals, while veterinary products dominated volume at lower prices. The market is highly concentrated, with Belgium supplying 73.45% of premium medical-grade imports by value and South Africa leading bulk shipments by weight. Supplier reliance on a few high-value manufacturers like Abbott Laboratories underscores supply chain risks, requiring strategic diversification. This analysis, covering March 2025, is based on cleanly processed Customs data from the yTrade database.

Botswana Blood Products Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood products, vaccines, toxins, and cultures. These products are critical for healthcare, pharmaceuticals, and research industries, driving consistent global demand due to their essential role in disease prevention and treatment. Botswana's Blood Products Import under this code reflects its reliance on these materials for medical and veterinary applications.

Current Context and Strategic Position

Under the 2025 trade agreement, Botswana applies annual tariff rate quotas to HS Code 3002 imports from MERCOSUR member states, as outlined in the [BURS tariff notes]. This policy underscores the need for market vigilance, as quota allocations could impact supply chains and pricing. Botswana's strategic position in hs code 3002 trade data highlights its dependence on imported blood products to meet domestic healthcare needs, making policy shifts a key factor for stakeholders. Monitoring these developments is essential to anticipate supply disruptions or cost fluctuations.

Botswana Blood Products Import (HS 3002) Price Trend

Key Observations

Botswana's Blood Products Import trend under HS code 3002 surged to $3.86 million in March 2025, with a unit price of $128.73 per kilogram, marking a significant peak in both value and pricing for the quarter.

Price and Volume Dynamics

The hs code 3002 value trend showed volatile momentum, with unit prices dropping from $61.25/kg in January to $42.80/kg in February before the sharp March rebound, while volumes consistently rose. This volatility aligns with adjustments to import costs following the implementation of new tariff rate quotas for MERCOSUR-originating goods, as detailed in the BURS policy update [BURS], likely prompting strategic stockpiling or shifted sourcing in the medical supply chain. The sequential growth in March reflects responsive import behavior to these regulatory changes, underscoring the sensitivity of blood product markets to trade policy shifts.

Botswana Blood Products Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

In March 2025, Botswana's import of blood products under HS Code 3002 is heavily concentrated in high-value human vaccines, according to yTrade data. The sub-code for human medicine vaccines (30024190) dominates with a 75% value share and a high unit price of 881 USD per kilogram, highlighting a specialization in premium, finished products. A separate high-value item, immunological preparations for retail sale (30021500), with an extreme unit price of 1,804 USD per kilogram, is noted as an anomaly and isolated from the main analysis due to its outlier pricing.

Value-Chain Structure and Grade Analysis

The remaining imports under HS Code 3002 for Botswana can be grouped into two categories: high-value human biologicals and lower-value veterinary products. Human-focused items like antisera and blood fractions (30021200) show medium unit prices around 102 USD per kilogram, indicating differentiated, semi-finished goods. In contrast, veterinary medicines (30024200) account for the majority of quantity with a low unit price of 23 USD per kilogram, pointing to a fungible bulk trade. This structure suggests a mix of specialized manufactured products and commodity-like volumes.

Strategic Implication and Pricing Power

For importers handling Botswana's HS Code 3002 trade data, this analysis indicates strong pricing power in high-value human biologicals due to their specialized nature, but more competitive dynamics in veterinary bulk imports. Strategic focus should prioritize securing stable supplies for high-margin human medicine segments while optimizing logistics for cost-effective veterinary product flows to maintain competitiveness.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Blood Products Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

In March 2025, Botswana's imports of Blood Products were highly concentrated, with Belgium dominating by value at 73.45% share, while South Africa led by weight with 82.70% share. The disparity shows Belgium's value share far exceeds its weight share, indicating a focus on higher-grade or finished blood products, likely for medical use. South Africa's weight share surpasses its value share, suggesting bulk or lower-end variants, possibly raw materials. South Africa also had a high frequency share of 46.20%, pointing to frequent, small-ticket shipments for regular supply chain needs.

Origin Countries Clusters and Underlying Causes

The origin countries for Botswana's Blood Products imports form three clusters. The high-yield cluster includes Belgium and Ireland, with high value shares but low weight, indicating premium, finished products from Europe. The volume/hub cluster is led by South Africa, with high weight share, acting as a key source for bulk supplies, possibly due to regional proximity. The transactional cluster involves South Africa, United States, and Netherlands, with notable frequency shares, reflecting just-in-time or regular shipment patterns for stable distribution.

Forward Strategy and Supply Chain Implications

Botswana's heavy reliance on Belgium for high-value Blood Products imports poses a supply chain risk, suggesting a need to diversify sources for premium items. South Africa's strong volume and frequency provide stability for bulk needs. Policy changes, such as tariff rate quotas from MERCOSUR members [BURS], could affect small partners like Uruguay, but current impact is minimal. Future strategy should balance high-value diversification with leveraging South Africa's efficient bulk supply for HS Code 3002 trade.

Table: Botswana Blood Products (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Blood Products (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

According to yTrade data, the Botswana Blood Products Import suppliers market in March 2025 shows a highly concentrated structure. The dominant group consists of infrequent but high-value suppliers, accounting for 74.99% of the total import value. Most trades involve frequent shipments with lower individual values, but the bulk of spending comes from a small number of large transactions. This indicates that the typical trade for Botswana's Blood Products import is characterized by regular, smaller purchases, while the majority of financial outlay is driven by occasional, significant orders.

Strategic Supplier Clusters and Trade Role

The dominant infrequent high-value suppliers, represented by manufacturers like ABBOTT LABORATORIES and PFIZER OVERSEAS LLC, suggest a Direct-to-Factory sourcing model for HS code 3002 suppliers. Other clusters include frequent high-value suppliers handling substantial but regular volumes, frequent low-value suppliers contributing minimal value through many small shipments, and infrequent low-value suppliers with negligible impact. This structure points to a market where key manufacturers directly supply large orders, while smaller players fill in with routine, lower-value transactions.

Sourcing Strategy and Vulnerability

For Botswana importers, the reliance on a few high-value manufacturers for Blood Products requires strategic focus on securing stable relationships and managing supply chain risks, such as potential delays or price fluctuations. Diversifying suppliers could mitigate vulnerabilities. The tariff rate quotas for MERCOSUR goods, as outlined in the [BURS] schedules, may influence sourcing costs and encourage exploration of alternative regions to optimize import strategies.

Table: Botswana Blood Products (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Blood Products Supplier lists

Action Plan for Blood Products Market Operation and Expansion

• Use hs code 3002 trade data to identify and negotiate directly with high-value, infrequent suppliers like major manufacturers, securing long-term contracts to lock in pricing and ensure a stable supply of premium human biologicals for the Botswana Blood Products Import market.
• Diversify the geographic sourcing for high-value items beyond Belgium by analyzing trade data for alternative European and North American suppliers, mitigating the significant supply chain risk posed by a single-point-of-failure for critical medical imports.
• Optimize the Blood Products supply chain by separating high-value, temperature-sensitive shipments from bulk veterinary product flows, leveraging South Africa’s high-frequency and high-volume role for cost-effective logistics of lower-value goods.
• Monitor hs code 3002 trade data for new or emerging suppliers from regions like MERCOSUR that may benefit from tariff rate quotas, providing opportunities to gradually diversify the supplier base and introduce competitive pricing for the Botswana Blood Products Import portfolio.

Take Action Now —— Explore Botswana Blood Products Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Blood Products Import 2025 March?

The surge to $3.86 million in March reflects volatile price dynamics, with unit prices rebounding sharply to $128.73/kg after a February dip. This aligns with strategic stockpiling or sourcing shifts due to new tariff policies affecting medical supply chains.

Q2. Who are the main origin countries of Botswana Blood Products (HS Code 3002) 2025 March?

Belgium dominates by value (73.45% share), while South Africa leads by weight (82.70%) and frequency (46.20%). Ireland is another key high-value origin.

Q3. Why does the unit price differ across origin countries of Botswana Blood Products Import?

Price gaps stem from product specialization: Belgium supplies high-grade human vaccines (881 USD/kg), while South Africa provides bulk veterinary products (23 USD/kg).

Q4. What should importers in Botswana focus on when buying Blood Products?

Prioritize securing stable high-value human biologicals (e.g., vaccines) from manufacturers like Abbott and Pfizer, while optimizing logistics for cost-effective veterinary bulk imports from South Africa.

Q5. What does this Botswana Blood Products import pattern mean for overseas suppliers?

European suppliers (Belgium/Ireland) hold pricing power for premium medical goods, while South African suppliers benefit from recurring bulk demand. Diversification opportunities exist for mid-tier human biologicals.

Q6. How is Blood Products typically used in this trade flow?

Imports are split between high-end human medical applications (vaccines, antisera) and lower-value veterinary bulk products, reflecting Botswana’s dual need for specialized healthcare and agricultural supplies.